ACTG A5164(V 20)-ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS W/ACUTE OIS
ACTG A5164(V 20)-ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS W/ACUTE OIS
批准号:
7377827
负责人:
THOMAS A CAMPBELL
金额:
$1.74万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2007-03-31
中文摘要
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。本研究的目的是了解在患者因成骨不全(机会性感染)或细菌性感染接受治疗时,是立即开始使用抗HIV药物更好,还是等到成骨不全或细菌性感染得到治疗后才开始使用。目前尚不清楚艾滋病药物是否会导致严重疾病患者(如OI或BI患者)病情恶化的副作用。本研究的另一个目的是比较在OI或BI期间或之后开始使用HIV药物的安全性和有效性。该子研究的目的是比较患者在接受呼吸道感染治疗期间和停止呼吸道感染治疗后血液中某些HIV药物的水平。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this study to learn whether it is better to start drugs that fight HIV right away, while a patient are being treated for an OI(opportunistic infection) or BI(bacterial infection), or wait until after the OI or BI has been treated. It is not known whether the HIV drugs cause side effects that could worsen the problems for seriously ill people such as those with OI or BI. Another purpose of this study is to compare the safety and effectiveness of the HIV drugs when started during or after an OI or BI. The purpose of the substudy is to compare the levels of some of the HIV drugs in the blood while a patient is receiving treatment for a respiratory infection and after they have stopped treatment for the respiratory infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG A5211-SAFETY AND EFFICACY OF SCH 417690 IN HIV-INF, TRTMNT-EXP SUBJCTS
-
批准号:7719470
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG 362-METAB,CARDIOVAS&NEUROLCOMPLICA'S IN SUBJ'S W/PAST CD4 CELL
-
批准号:7719416
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5095 -PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV
-
批准号:7719426
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
EVALOF EFFICACY OF ONCE/DAY PROTEASE INHBTR& ONCE/DAY NONNUCLEOSIDE REVERSE
-
批准号:7719467
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5001 - LONGITUDINAL LINKED RANDOMIZED TRIALS (ALLRT) PROTOCOL
-
批准号:7719419
-
项目类别:
-
资助金额:$4.22万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
MEASURE CLEARANCE OF REPLICATION-COMPETENT HIV-1 IN RESTING MEMORY CD4+ CELLS
-
批准号:7719441
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5164(V 20)-ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS W/ACUTE OIS
-
批准号:7719463
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
CEREBRAL & NEUROCOGNITIVE FNCTN IN HIV-INFECTED PRSNS W/ADVNCD HRT DISZ ON HAART
-
批准号:7719523
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5146:IMPACT OF THERAPEUTIC DRUG MONITORING (TDM) ON VIROLOGIC RESPONSE
-
批准号:7719430
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5202 (VS 10): TRIAL OF OPEN-LABEL EFAVIRENZ OR ATAZANAVIR WITH RITONAVIR
-
批准号:7719505
-
项目类别:
-
资助金额:$5.61万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5030-VALGANCICLOVIR PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS (CMV) VIREMIA
-
批准号:7719423
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
SUPPRESSIVE LONG-TERM ANTIVIRAL MGMT OF HCV & HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7719464
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2008
-
负责人:THOMAS A CAMPBELL
-
依托单位:
CEREBRAL & NEUROCOGNITIVE FNCTN IN HIV-INFECTED PRSNS W/ADVNCD HRT DISZ ON HAART
-
批准号:7604473
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5202 (VS 10): TRIAL OF OPEN-LABEL EFAVIRENZ OR ATAZANAVIR WITH RITONAVIR
-
批准号:7604455
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
EVALOF EFFICACY OF ONCE/DAY PROTEASE INHBTR& ONCE/DAY NONNUCLEOSIDE REVERSE
-
批准号:7604417
-
项目类别:
-
资助金额:$9.76万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5095 -PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV
-
批准号:7604376
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5146:IMPACT OF THERAPEUTIC DRUG MONITORING (TDM) ON VIROLOGIC RESPONSE
-
批准号:7604380
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG 362-METAB,CARDIOVAS&NEUROLCOMPLICA'S IN SUBJ'S W/PAST CD4 CELL
-
批准号:7604366
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5001 - LONGITUDINAL LINKED RANDOMIZED TRIALS (ALLRT) PROTOCOL
-
批准号:7604369
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
ACTG A5030-VALGANCICLOVIR PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS (CMV) VIREMIA
-
批准号:7604373
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:THOMAS A CAMPBELL
-
依托单位:
海外基金